• In Vitro Activity of Midecamycin: 1983 Study Review

  2026-08-28

  Harold C. Neu’s 1983 study established an early comparative profile for Midecamycin, an acetoxy-substituted macrolide antibiotic, across clinically derived Gram-positive and Gram-negative isolates. The results showed useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but lower potency than erythromycin and no meaningful activity against erythromycin-resistant isolates or most tested Gram-negative bacilli.

• Amorolfine Hydrochloride in Yeast Integrity Assays

  2026-08-28

  Use Amorolfine Hydrochloride as a controlled membrane-stress probe in yeast ploidy, viability, and antifungal mechanism studies. This workflow connects cell-size limits with fungal cell membrane disruption while emphasizing solvent control, fresh solutions, and assay-specific optimization.

• Sodium Oxamate: Beyond a Glycolysis Blocker

  2026-08-27

  Sodium Oxamate is more than a Warburg effect inhibitor: it is a powerful tool for separating glycolytic flux, lactate signaling, and histone lactylation. This article examines how a recent intracerebral hemorrhage study changes experimental interpretation and assay design.

• T0070907 as a Causal Probe of PPARγ Signaling

  2026-08-27

  T0070907 is a high-affinity PPARγ antagonist for dissecting receptor-dependent transcription, adipogenesis, and cell-cycle phenotypes. This article translates recent RXRα/PPARγ/NEDD4 findings into a practical assay strategy that distinguishes pathway correlation from causation.

• Cyanidin Chloride: Identity-to-Barrier Assay Design

  2026-08-26

  Cyanidin Chloride can connect reactive oxygen species scavenging with inflammatory and epithelial-barrier endpoints, but only when chemical identity is verified. This guide develops an identity-aware workflow for oxidative stress research using orthogonal assays and careful interpretation of related cyanin chloride evidence.

• ECL Western Blotting Substrate Workflow

  2026-08-26

  ECL Western Blotting Substrate (SKU K2187) provides luminol-based, nonradioactive detection of HRP-conjugated proteins on immunoblots, with signal capture by X-ray film or CCD imaging. It is intended for HRP chemiluminescence workflows and should not be used as a fluorescent or radioisotopic detection reagent.

• Mianserin HCl: 5-HT2 Antagonist Research Guide

  2026-08-25

  Mianserin HCl is a tetracyclic antidepressant research compound with noradrenergic activity and 5-HT2 receptor antagonism. Its cyclodextrin complexes have measurable binding and can increase cytotoxicity in cell assays, so formulation effects must be separated from intrinsic receptor pharmacology.

• Talabostat Mesylate: Research Workflows

  2026-08-25

  Talabostat mesylate (PT-100) supports two complementary research directions: pharmacologic interrogation of keratinocyte NLRP1 responses and mechanistic studies of DPP4/FAP biology in cancer models. This practical guide covers model selection, dosing, assay controls, optimization, and the limitations that determine whether results are reproducible.

• GSK343: Reliable EZH2 Inhibition in Cell Assays

  2026-08-24

  A scenario-based guide to using GSK343 (SKU A3449) for EZH2-focused viability, proliferation, and epigenetic cancer research. It connects biochemical potency with cellular H3K27me3 and phenotype readouts while addressing formulation, controls, interpretation, and vendor-selection decisions.

• Midecamycin: From MIC to Mechanism

  2026-08-24

  Midecamycin is an acetoxy-substituted macrolide antibiotic whose value extends beyond a single MIC result. This article connects ribosomal mechanism, assay design, resistance interpretation, and formulation choices into a practical framework for microbiology research.

• QPRT, MLCK, and Breast Cancer Invasion

  2026-08-23

  The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a promoter of breast cancer cell migration and invasion and links this metabolic enzyme to myosin light chain phosphorylation. Its combination of genetic perturbation, pharmacologic pathway analysis, and tumor-model evidence provides a framework for studying how NAD+-related metabolism influences actomyosin-dependent invasion.

• Fluo-4 AM Calcium Assay Kit for Mechanobiology

  2026-08-22

  Translate scaffold-induced mechanosensing into a live-cell calcium signal with a 488 nm-compatible, no-wash workflow. The same platform can connect annulus fibrosus mechanobiology with scalable GPCR inhibitor and agonist screening while preserving cells for downstream phenotype analysis.

• EZH2 Inhibitors in HPV-Associated Cervical Cancer

  2026-08-22

  The reference study evaluates EPZ-6438 and ZLD1039 as EZH2 inhibitors in HPV-positive and HPV-negative cervical cancer models. Its integrated proliferation, apoptosis, cell-cycle, molecular, and chorioallantoic membrane analyses suggest that EZH2 blockade can suppress HPV-associated tumor phenotypes while providing a mechanistically distinct comparator to cisplatin.

• Novobiocin Workflows for Antimicrobial Research

  2026-08-21

  Novobiocin supports more than routine antibacterial screening: it can connect DNA gyrase, Hsp90, membrane, parasite, and viral assays in a controlled workflow. This guide adapts a quantitative synergy method from oral microbiology to practical dose–response, mechanism, and troubleshooting strategies.

• APEX2 Enables TERT Expression in Human Stem Cells

  2026-08-20

  The reference preprint identifies APEX2 as a DNA repair enzyme required for efficient TERT expression and telomerase activity in human embryonic stem cells, distinguishing its role from the related enzyme APEX1. By combining knockdown, RNA sequencing, and chromatin immunoprecipitation, the study links APEX2-dependent transcription to damage-prone repetitive DNA, particularly MIR elements within the TERT locus.

8112 records 6/541 page Previous Next First page 上5页 678910 下5页 Last page